Sign in
4

Changes in Ownership

Protalix BioTherapeutics, Inc. Filed Acc 0001104659-23-093066

Sr. VP, Operations acquired 187,344 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Naos Yaron Sr. VP, Operations 2023-08-15 Grant or award +187,344 200,817 I
Loading xslF345X05/tm2324046-1_4seq1.xml…